Cargando…

BAHAMA: A Bayesian Hierarchical Model for the Detection of MedDRA(®)-Coded Adverse Events in Randomized Controlled Trials

INTRODUCTION: Patients participating in randomized controlled trials (RCTs) are susceptible to a wide range of different adverse events (AE) during the RCT. MedDRA(®) is a hierarchical standardization terminology to structure the AEs reported in an RCT. The lowest level in the MedDRA hierarchy is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Revers, Alma, Hof, Michel H., Zwinderman, Aeilko H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402776/
https://www.ncbi.nlm.nih.gov/pubmed/35840802
http://dx.doi.org/10.1007/s40264-022-01208-w
_version_ 1784773232920887296
author Revers, Alma
Hof, Michel H.
Zwinderman, Aeilko H.
author_facet Revers, Alma
Hof, Michel H.
Zwinderman, Aeilko H.
author_sort Revers, Alma
collection PubMed
description INTRODUCTION: Patients participating in randomized controlled trials (RCTs) are susceptible to a wide range of different adverse events (AE) during the RCT. MedDRA(®) is a hierarchical standardization terminology to structure the AEs reported in an RCT. The lowest level in the MedDRA hierarchy is a single medical event, and every higher level is the aggregation of the lower levels. METHOD: We propose a multi-stage Bayesian hierarchical Poisson model for estimating MedDRA-coded AE rate ratios (RRs). To deal with rare AEs, we introduce data aggregation at a higher level within the MedDRA structure and based on thresholds on incidence and MedDRA structure. RESULTS: With simulations, we showed the effects of this data aggregation process and the method's performance. Furthermore, an application to a real example is provided and compared with other methods. CONCLUSION: We showed the benefit of using the full MedDRA structure and using aggregated data. The proposed model, as well as the pre-processing, is implemented in an R-package: BAHAMA.
format Online
Article
Text
id pubmed-9402776
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-94027762022-08-26 BAHAMA: A Bayesian Hierarchical Model for the Detection of MedDRA(®)-Coded Adverse Events in Randomized Controlled Trials Revers, Alma Hof, Michel H. Zwinderman, Aeilko H. Drug Saf Original Research Article INTRODUCTION: Patients participating in randomized controlled trials (RCTs) are susceptible to a wide range of different adverse events (AE) during the RCT. MedDRA(®) is a hierarchical standardization terminology to structure the AEs reported in an RCT. The lowest level in the MedDRA hierarchy is a single medical event, and every higher level is the aggregation of the lower levels. METHOD: We propose a multi-stage Bayesian hierarchical Poisson model for estimating MedDRA-coded AE rate ratios (RRs). To deal with rare AEs, we introduce data aggregation at a higher level within the MedDRA structure and based on thresholds on incidence and MedDRA structure. RESULTS: With simulations, we showed the effects of this data aggregation process and the method's performance. Furthermore, an application to a real example is provided and compared with other methods. CONCLUSION: We showed the benefit of using the full MedDRA structure and using aggregated data. The proposed model, as well as the pre-processing, is implemented in an R-package: BAHAMA. Springer International Publishing 2022-07-15 2022 /pmc/articles/PMC9402776/ /pubmed/35840802 http://dx.doi.org/10.1007/s40264-022-01208-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research Article
Revers, Alma
Hof, Michel H.
Zwinderman, Aeilko H.
BAHAMA: A Bayesian Hierarchical Model for the Detection of MedDRA(®)-Coded Adverse Events in Randomized Controlled Trials
title BAHAMA: A Bayesian Hierarchical Model for the Detection of MedDRA(®)-Coded Adverse Events in Randomized Controlled Trials
title_full BAHAMA: A Bayesian Hierarchical Model for the Detection of MedDRA(®)-Coded Adverse Events in Randomized Controlled Trials
title_fullStr BAHAMA: A Bayesian Hierarchical Model for the Detection of MedDRA(®)-Coded Adverse Events in Randomized Controlled Trials
title_full_unstemmed BAHAMA: A Bayesian Hierarchical Model for the Detection of MedDRA(®)-Coded Adverse Events in Randomized Controlled Trials
title_short BAHAMA: A Bayesian Hierarchical Model for the Detection of MedDRA(®)-Coded Adverse Events in Randomized Controlled Trials
title_sort bahama: a bayesian hierarchical model for the detection of meddra(®)-coded adverse events in randomized controlled trials
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402776/
https://www.ncbi.nlm.nih.gov/pubmed/35840802
http://dx.doi.org/10.1007/s40264-022-01208-w
work_keys_str_mv AT reversalma bahamaabayesianhierarchicalmodelforthedetectionofmeddracodedadverseeventsinrandomizedcontrolledtrials
AT hofmichelh bahamaabayesianhierarchicalmodelforthedetectionofmeddracodedadverseeventsinrandomizedcontrolledtrials
AT zwindermanaeilkoh bahamaabayesianhierarchicalmodelforthedetectionofmeddracodedadverseeventsinrandomizedcontrolledtrials